跳至主要内容
临床试验/NCT04654650
NCT04654650招募中不适用

Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension

Universitätsklinikum Hamburg-Eppendorf1 个研究点 分布在 1 个国家目标入组 5,000 人开始时间: 2021年1月26日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
5,000
试验地点
1
主要终点
Transplant-free survival

研究概览

简要总结

Prospective registry and biobank for long-term observational studies in adult patients with pulmonary hypertension

详细描述

In a prospective registry prevalent and incident patients diagnosed with group 1 to 5 pulmonary hypertension will be enrolled. In an integrated biobank body fluid samples will be collected at enrollment and sequentially during treatment with targeted drugs for pulmonary hypertension.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of pulmonary hypertension group 1 to 5
  • Ability to give informed consent

排除标准

  • Withdrawal of informed consent

结局指标

主要结局

Transplant-free survival

时间窗: Up to 20 years of follow-up after enrollment

次要结局

  • Risk score (averaging low, intermediate and high risk categories) as proposed by the 2015 European Society of Cardiology (ESC)/European Respiratory Society (ERS) guidelines for pulmonary hypertension(Up to 20 years of follow-up after enrollment)
  • Registry to Evaluate Early And Long-term PAH Disease Management (REVEAL) 2.0 risk score(Up to 20 years of follow-up after enrollment)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验